Development of Fluconazole Resistance in Candida albicans Causing Disseminated Infection in a Patient Undergoing Marrow Transplantation

Marr, Kieren A., White, Theodore C., van Burik, Jo‐Anne H., Bowden, Raleigh A.·1997·Clinical Infectious Diseases
DOI 10.1086/515553

Cited by (142)

Items 101–142 of 142

  1. Experimental and in-host evolution of triazole resistance in human pathogenic fungi
    Mariana Handelman, Nir Osherov · 2022 · Frontiers in Fungal Biology
  2. Oral candidiasis prevention in transplantation patients: a comparative study
    Sharon Elad, Alon Wexler, Adi A. Garfunkel, Michael Y. Shapira, Menachem Bitan, Reuven Or · 2006 · Clinical Transplantation
  3. Characterization of caspofungin susceptibilities by broth and agar inCandidaalbicansclinical isolates with characterized mechanisms of azole resistance
    Peter M. Silver, Peter M. Silver, Brian Gregory George Oliver, Theodore C. White · 2008 · Medical Mycology
  4. Synthesis and in vitro Evaluation of Antifungal Properties of Some 4-Aryl-3-Methyl-1,2,3,4-Tetrahydroquinolines Derivatives
    Arnold R. Romero Bohórquez, Vladímir V. Kouznetsov, Susana A. Zacchino · 2014 · Universitas Scientiarum
  5. Use of posaconazole in the treatment of invasive fungal infections
    Aneesh K. Mehta, Amelia A. Langston · 2009 · Expert Review of Hematology
  6. Linseed polyol-assisted, microwave-induced synthesis of nano CuO embedded in polyol-polyester matrix: antifungal behavior and coating properties
    Eram Sharmin, Sheikh Shreaz, Fahmina Zafar, Deewan Akram, Vaseem Raja, Sharif Ahmad · 2017 · Progress in Organic Coatings
  7. Characterization, heterologous expression and functional analysis of mevalonate diphosphate decarboxylase gene (MVD) of Candida albicans
    Ranil Samantha Dassanayake, Liang Cao, Lakshman Perera Samaranayake, Thierry Bergès · 2002 · Molecular Genetics and Genomics
  8. Yeasts and fluconazole susceptibility in the Philippines
    Glenn S. Bulmer, Ma. Lourdes Marquez, L. Coo-Barcelona, Robert A. Fromtling · 1999 · Mycopathologia
  9. Low Levels of Antigenic Variability in Fluconazole-Susceptible and -Resistant Candida albicans Isolates from Human Immunodeficiency Virus-Infected Patients with Oropharyngeal Candidiasis
    Jose Luis Lopez-Ribot, Robert K. McAtee, William R. Kirkpatrick, Roberto La Valle, Thomas F. Patterson · 1999 · Clinical and Diagnostic Laboratory Immunology
  10. Copy Number Variation and Allele Ratio Analysis in Candida albicans Using Whole Genome Sequencing Data
    Robert T. Todd, Anna M. Selmecki · 2023 · Methods in molecular biology
  11. Prise en charge des infections systémiques à Candida spp.
    Fabien Taieb, Frederic Mechai, Agnès Lefort, Fanny Lanternier, Marie‐Elisabeth Bougnoux, Olivier Lortholary · 2010 · La Revue de Médecine Interne
  12. Resistance to Antifungal Agents
    Beth A. Arthington, John H. Rex · 2007 · Springer eBooks
  13. Fluconazole in transplant recipients: options and limitations
    Jacob Strahilevitz, Alan M. Sugar, Dan Engelhard · 2000 · Transplant Infectious Disease
  14. Mechanisms of Resistance to Antifungal Agents
    David S. Perlin · 2015 · ASM Press eBooks
  15. Therapeutic armamentarium against systemic fungal infections
    José Miguel Cisneros, Elisa Cordero · 2006 · Clinical Microbiology and Infection
  16. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2017 · Springer eBooks
  17. Antifungal susceptibility against yeasts isolated from pediatric oncology patients
    Leslie S. Kersun, Anne F. Reilly, M. E. Ingram, Matthew Nicholaou, Karin L. McGowan · 2008 · Medical Mycology
  18. Susceptibility of 57 Bloodstream and Urinary Isolates of Candida Species from a Single Children’s University Hospital to 6 Antifungals
    Juraj Hanzen, L Pevalová, M Benedeková, Gabriela Kovacicova, Adriana Ondrusova, Maria Huttova, Vladimir Krcmery · 2002 · Chemotherapy
  19. Characterization of a New Hsp110 Inhibitor as a Potential Antifungal
    Cancan Sun, Yi Li, Justin M. Kidd, Jizhong Han, Liang‐Liang Ding, Aaron E. May, Lei Zhou, Qinglian Liu · 2024 · Journal of Fungi
  20. Specific Chromosome Alterations ofCandida albicans: Mechanisms for Adaptation to Pathogenicity
    Elena P. Rustchenko · 2014 · ASM Press eBooks
  21. Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment
    Siret Ratıp, Zekaver Odabaşı, Suleyman Sami Karti, M. Çetiner, Cumhur Yeğen, Nilgün Çerikçioğlu, Mahmut Bayık, Volkan Korten · 2002 · Clinical Microbiology and Infection
  22. Advances in Antifungal Susceptibility Testing of Candida, 2010–2012
    Michael A. Pfaller, Mariana Castanheira, Ronald N. Jones · 2012 · Current Fungal Infection Reports
  23. The Role of Resistance in Candida Infections: Epidemiology and Treatment
    Jack D. Sobel, Robert A. Akins · 2009 · Humana Press eBooks
  24. Incidence and Management of Proven and Probable Fungal Infections in Patients with Acute Leukemia: A Single Center Experience
    Rosa Fanci, Cinzia Casini, F. Leoni, Stefania Ciolli, Alberto Bosi · 2004 · Journal of Chemotherapy
  25. Fungal Infections in Surgical Patients
    Pamela A. Lipsett · 2002 · Problems in General Surgery
  26. Resistance to Antifungal Agents
    Sevtap Arıkan, John H. Rex · 2010 · Wiley eBooks
  27. Clinical microbiological case: chronic disseminated candidiasis unresponsive to treatment
    Siret Ratıp, Z. Odabaşi, S. Sami Karti, M. Çetiner, C. Yeğen, N. Çerikcioğlu, M. Bayik, V. Korten · 2002 · Clinical Microbiology and Infection
  28. FKS1/2-variant independent mechanisms underlying the emergence of resistance in echinocandin-refractory Candida auris infections
    Hugh Gifford, Arnab Pradhan, Ben A Caswall, Sarah E. Murphy, Ian Leaves, Matt B. Edmondson, Tanmoy Chakraborty, Duncan Wilson, Surabhi K. Taori, Neil A. R. Gow et al. · 2026 · Nature Communications
  29. Antifungal Prophylaxis and Therapy: Controversies and Emerging Issues
    Edward A. Dominguez · 2001 · Perspectives on critical care infectious diseases
  30. Controversial Points in the Treatment of Patients with Haematologic Malignancies Complicated with Systemic Fungal Infections.
    Takeshi Mori · 1999 · Nippon Ishinkin Gakkai Zasshi
  31. Candida: Some Thoughts
    N. Soni · 2000 · Yearbook of intensive care and emergency medicine
  32. Pathogens in Sepsis: Fungi, Parasites
    Frederic Mechai, Fabrice Bruneel, Fanny Lanternier, Stéphane Legriel, Jean‐Pierre Bédos, Olivier Lortholary · 2008 · Wiley eBooks
  33. Emergence of Candida albicans fungemia during voriconazole therapy
    I. Mohammédi, Anne Thiébaut, M. A. Piens, Laurent Argaud, O. Martin, Dominique Robert · 2004 · Journal of Infection
  34. Actualización diagnóstica y terapéutica en infecciones fúngicas invasoras: de los antiguos tópicos a las nuevas evidencias
    Carmen Partera Luque, José Miguel Cisneros · 2001 · Farmacia Hospitalaria
  35. Fungal Infections in Stem Cell Transplant Recipients
    Dionysios Neofytos, Kieren A. Marr · 2010 · Springer eBooks
  36. Figure 1. Long - term culture of retrovirally transduced CD34
    Ngaire J. Elwood · 2004
  37. Desenvolupament experimental de nous tractaments antifúngics per infeccions causades per llevats
    Marçal Mariné Mestres · 2010 · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
  38. Newer Antifungal Agents in Pediatrics
    Christina Henn, William J. Steinbach · 2009 · CRC Press eBooks
  39. Fungal infections: an infection control perspective
    Christopher H. Heath · 2002 · Australian Infection Control
  40. Prophylaxis and Treatment of Invasive Fungal Infections in Neutropenic Cancer and Hematopoietic Stem Cell Transplant Patients
    Selmin Ataergın, Hillard Michael Lazarus · 2009 · CRC Press eBooks
  41. Advances in yeast and mold monodrug and combination drug antifungal susceptibility testing
    Tracy J. Wetter · 2004 · Montana State University ScholarWorks (Montana State University)
  42. Molecular mechanisms of aneuploidy-mediated stress-resistance
    Andrei Kucharavy · 2017 · theses.fr (ABES)